Article Details
Retrieved on: 2019-03-17 08:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Surrozen Inc., a San Francisco, CA-based biopharmaceutical company, secured $50m in Series B financing. Backers included <b>Horizons Ventures</b>, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here